Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
Nicole M. Kuderer, Kerry L. Reynolds(Massachusetts General Hospital), Mateo Bover Larroya(Hospital Universitario 12 De Octubre), Navid Hafez(Smilow Cancer Hospital), Salvatore A. Del Prete(Stamford Hospital), Anup Kasi(University of Kansas Medical Center), Prakash Peddi(Willis-Knighton Cancer Center), Deborah B. Doroshow(Icahn School of Medicine at Mount Sinai), Jessica E. Hawley(Columbia University Irving Medical Center), Ali Raza Khaki(Palo Alto Institute), Dimitrios Farmakiotis(Brown University), Daniel Flora(St. Elizabeth Healthcare), Shilpa Gupta(Cleveland Clinic), Matthew D. Galsky(Icahn School of Medicine at Mount Sinai), Christopher A. Lemmon(Cleveland Clinic), Daniel Castellano(Universidad Complutense de Madrid), Nathaniel Bouganim(McGill University Health Centre), Petros Grivas(Seattle Cancer Care Alliance), Gerald Batist(Jewish General Hospital), Ziad Bakouny(Dana-Farber Cancer Institute), Mary F. Mulcahy(Northwestern University), Chih–Yuan Hsu(Vanderbilt University Medical Center), Ruben A. Mesa(Atrium Health Wake Forest Baptist), Dimpy P. Shah(The University of Texas MD Anderson Cancer Center), Arielle Elkrief(Centre Hospitalier de l’Université de Montréal), Anthony P. Gulati(Stamford Hospital), Mehmet Asım Bilen(Emory Healthcare), Corrie Painter, Toni K. Choueiri(Harvard University), Colleen Lewis(Emory University), Rana R. McKay(University of California San Diego), Elizabeth A. Griffiths(Roswell Park Comprehensive Cancer Center), Yu Shyr(Vanderbilt University), Solange Peters(University Hospital of Lausanne), Donna R. Rivera(National Cancer Institute), Gilberto Lopes(University of Miami), Alicia K. Morgans(Dana-Farber Cancer Institute), Tyler Masters(Smilow Cancer Hospital), Tanios Bekaii‐Saab(WinnMed), Emily Hsu(University of Connecticut), Barbara Logan(St. Elizabeth Healthcare), Aakash Desai(University of Connecticut), Samuel M. Rubinstein(Vanderbilt University Medical Center), Orestis A. Panagiotou(Brown University), Þorvarður R. Hálfdánarson(Mayo Clinic), Pamela Egan(Brown University), Nathan A. Pennell(Cleveland Clinic), Michael Glover(Stanford University), Sanjay Shete(The University of Texas MD Anderson Cancer Center)
Cited by 1,801
Related Papers
The Immune Landscape of Cancer
|Immunity|2018|6.2k
Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
|New England Journal of Medicine|2017|3.4k